glp-1 and naion RAs NAION: No increased risk in large US study | Paramesh Shamanna posted on the topic Document Title

Pfizer (NYSE:PFE) reported positive Phase 2b VESPER-3 data for its monthly injectable GLP-1 obesity therapy acquired from Metsera

For drugs with a narrow therapeutic index, other factors need to be monitored closely, including plasma drug levels, patients clinical outcomes, and laboratory markers

Medical News Today asks four experts to weigh in on the trend of trying to get a fifth dose out of Mounjaro.

One popular health platforms is promoting GLP-1 microdosing for weight loss: But how safe and effective is this approach

A doctor explains what to do when you miss, run out or cant refill your medication

Clear graduated barrel with easy to read graduated numbers Suitable for industrial, scientific, or household use